docetaxel anhydrous has been researched along with Ascites in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (12.00) | 18.2507 |
| 2000's | 9 (36.00) | 29.6817 |
| 2010's | 12 (48.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aghighi, M; Crossland, D; Samankan, S; Taherian, M | 1 |
| He, Y; Lan, Z; Yang, F | 1 |
| Chen, WM; Liu, EL; Mi, RR; Wang, DH; Wang, LQ; Zhang, YM | 1 |
| Hata, M; Okada, A; Taeda, Y; Ushijima, R | 1 |
| Hosoda, Y; Inoue, K; Ito, K; Kanazawa, R; Miyagi, Y; Shibahara, H; Takeuchi, S; Toyoda, S; Tsubamoto, H | 1 |
| Agarwal, A; Azabdaftari, G; Covic, L; Kaneider, NC; Kuliopulos, A; Lazarides, K; Sevigny, LM; Sharifi, S | 1 |
| Ito, C; Kamijo, Y; Miyamoto, K; Nomura, M; Sai, Y | 1 |
| Hasegawa, H; Kijima, T; Kitahara, M; Kubo, H; Miyahara, M; Tada, K | 1 |
| Allen, CJ; De Souza, R; Moriyama, EH; Piquette-Miller, M; Wilson, BC; Zahedi, P | 1 |
| Beretov, J; Chao, H; Chen, H; Hao, J; Kearsley, JH; Li, Y; Perkins, AC; Pourgholami, MH; Wang, L | 1 |
| Coudillo-Luna, I; Novoa-Vargas, A; Sánchez-Bautista, K | 1 |
| Asukai, K; Hasegawa, I; Horiguchi, N; Koguchi, H; Matsunaga, S; Miura, A; Ohno, T; Sakakibara, K; Shimizu, S; Togawa, S | 1 |
| Aoki, Y; Higashiguchi, T; Iwakura, S; Kunimoto, H; Nakase, T; Shimada, K; Shimamoto, T | 1 |
| Fujii, M; Funada, T; Jinno, D; Kaiga, T; Kanamori, N; Kochi, M; Mihara, Y; Shimizu, H; Takayama, T; Tamegai, H | 1 |
| Furui, N; Furukawa, H; Fushida, S; Ishizaki, J; Jin, M; Miwa, K; Miyamoto, K; Nomura, M; Yamazaki, M; Yokogawa, K; Yoshihara, H | 1 |
| Dentler, MD; Desai, PB; Einhaus, CM; Jakate, AS; Perrotta, AO; Retzinger, AC; Retzinger, GS | 1 |
| Fujiki, H; Kadotani, Y; Kumano, T; Mitsuo, M; Morita, S; Oda, T; Sonoyama, Y; Yasuoka, R | 1 |
| Chiba, M; Kawaguch, A; Mekata, E; Morii, H; Naitoh, H; Tan, T; Yamamoto, H | 1 |
| Büchler, MW; Büchler, P; Eibl, G; Friess, H; Hines, OJ; Isacoff, WH; Reber, HA; Roth, MA | 1 |
| Geng, M; Ji, YB; Jiang, JS; Li, H; Lou, GY; Ma, T; Xi, WQ; Xia, HQ; YeE, ZB | 1 |
| Miyade, Y; Ninomiya, M; Ohtani, S; Shimizu, Y; Sugiyama, S | 1 |
| Ember, A; Esik, O; Horváth, OP; Kalmár, K; Papp, A; Yousuf, AF | 1 |
| D'Incalci, M; Giavazzi, R; Lucchini, V; Nicoletti, MI | 1 |
| Davison, JD; Francis, PA; Ganju, V; Michael, M; Millward, MJ; Rischin, D; Shapiro, JD; Toner, GC | 1 |
| de Boer-Dennert, M; Pronk, LC; Stoter, G; van Beurden, V; van Putten, WL; Verweij, J | 1 |
2 review(s) available for docetaxel anhydrous and Ascites
| Article | Year |
|---|---|
[A case of liver metastasis of primary duodenal cancer effectively treated with docetaxel therapy].
Topics: Aged; Antineoplastic Agents; Ascites; Docetaxel; Duodenal Neoplasms; Humans; Liver Neoplasms; Male; Taxoids | 2013 |
[Malignant arrhenoblastoma. Case report and literature review].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Ascites; Carboplatin; Combined Modality Therapy; Diagnostic Imaging; Docetaxel; Female; Humans; Hysterectomy; Ovarian Neoplasms; Ovariectomy; Pleural Effusion, Malignant; Sertoli-Leydig Cell Tumor; Taxoids; Virilism | 2011 |
3 trial(s) available for docetaxel anhydrous and Ascites
| Article | Year |
|---|---|
Application of combined intraperitoneal and intravenous neoadjuvant chemotherapy in senile patients with advanced ovarian cancer and massive ascites.
Topics: Administration, Intravenous; Aged; Alzheimer Disease; Antineoplastic Combined Chemotherapy Protocols; Ascites; Blood Loss, Surgical; Carcinoma, Ovarian Epithelial; Chemotherapy, Adjuvant; Cisplatin; Cytoreduction Surgical Procedures; Disease-Free Survival; Docetaxel; Female; Humans; Infusions, Parenteral; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Operative Time; Ovarian Neoplasms; Survival Rate; Taxoids | 2017 |
Feasibility and efficacy of intraperitoneal docetaxel administration as salvage chemotherapy for malignant gynaecological ascites.
Topics: Adenocarcinoma, Clear Cell; Aged; Antineoplastic Agents; Ascites; Docetaxel; Feasibility Studies; Female; Genital Neoplasms, Female; Humans; Infusions, Parenteral; Middle Aged; Retrospective Studies; Salvage Therapy; Taxoids | 2015 |
The venotonic drug hydroxyethylrutosiden does not prevent or reduce docetaxel-induced fluid retention: results of a comparative study.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Ascites; Breast Neoplasms; Docetaxel; Edema; Humans; Hydroxyethylrutoside; Middle Aged; Paclitaxel; Pericardial Effusion; Pleural Effusion; Taxoids; Water-Electrolyte Imbalance | 1999 |
20 other study(ies) available for docetaxel anhydrous and Ascites
| Article | Year |
|---|---|
Pigs in a blanket: an unusual presentation of malignant ascites in prostatic adenocarcinoma.
Topics: Adenocarcinoma; Aged, 80 and over; Antineoplastic Agents; Ascites; Benzamides; Docetaxel; Humans; Male; Nitriles; Peritoneal Neoplasms; Phenylthiohydantoin; Prostatic Neoplasms; Treatment Outcome | 2019 |
Gastric squamous cell carcinoma presenting in ascites: Negative to P63 and P40 after one course of chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Ascites; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Female; Gastroscopy; Gene Expression; Humans; Keratins; Lymphatic Metastasis; Membrane Proteins; Middle Aged; NF-KappaB Inhibitor alpha; Stomach; Stomach Neoplasms; Tomography, X-Ray Computed | 2020 |
Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Ascites; Body Fluids; Cell Line, Tumor; Cell Movement; Disease Progression; Docetaxel; Female; Fibroblasts; Humans; Metalloproteases; Mice; Mice, Nude; Neoplasm Invasiveness; Neovascularization, Pathologic; NIH 3T3 Cells; Oligopeptides; Ovarian Neoplasms; Peritoneum; Receptor, PAR-1; Signal Transduction; Taxoids; Xenograft Model Antitumor Assays | 2008 |
Surfactants influence the distribution of taxanes in peritoneal dissemination tumor-bearing rats.
Topics: Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Ascites; Biological Transport; Carcinoma, Hepatocellular; Cell Line, Tumor; Docetaxel; Female; Glycerol; Injections, Intraperitoneal; Liver Neoplasms; Paclitaxel; Peritoneal Neoplasms; Polysorbates; Rats; Surface-Active Agents; Taxoids; Tissue Distribution | 2010 |
[Two cases of advanced gastric cancer with peritoneal dissemination, and Virchow's metastases successfully treated by combination therapy of S-1 and docetaxel].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Ascites; Docetaxel; Drug Combinations; Female; Gastrectomy; Humans; Lymphatic Metastasis; Male; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Peritonitis; Stomach Neoplasms; Taxoids; Tegafur | 2010 |
Continuous docetaxel chemotherapy improves therapeutic efficacy in murine models of ovarian cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Ascites; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Docetaxel; Female; Humans; Immunohistochemistry; Injections, Intraperitoneal; Mice; Neovascularization, Pathologic; Ovarian Neoplasms; Taxoids; Time Factors; Treatment Outcome | 2010 |
Anti-MUC1 monoclonal antibody (C595) and docetaxel markedly reduce tumor burden and ascites, and prolong survival in an in vivo ovarian cancer model.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Ascites; Biomarkers, Tumor; CA-125 Antigen; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Mice; Mice, Nude; Mucin-1; Ovarian Neoplasms; Platelet Endothelial Cell Adhesion Molecule-1; Survival Analysis; Taxoids; Tumor Burden; Xenograft Model Antitumor Assays | 2011 |
[A case of gastric cancer with peritoneal dissemination who achieved long survival from control of ascites for over 2 years by successive treatments with S-1 in combination with docetaxel as first-line followed by irinotecan in combination with cisplatin
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Camptothecin; Cisplatin; Docetaxel; Drug Combinations; Fatal Outcome; Humans; Irinotecan; Male; Oxonic Acid; Peritoneal Neoplasms; Salvage Therapy; Stomach Neoplasms; Taxoids; Tegafur | 2012 |
[A case of gastric cancer with peritoneal dissemination and massive ascites successfully treated with S-1/docetaxel therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Ascites; Biopsy; Docetaxel; Drug Combinations; Female; Humans; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids; Tegafur; Tomography, X-Ray Computed | 2012 |
Pharmacokinetics of docetaxel in gastric cancer patients with malignant ascites.
Topics: Aged; Antineoplastic Agents, Phytogenic; Ascites; Docetaxel; Female; Gastrectomy; Humans; Injections, Intravenous; Male; Middle Aged; Peritoneal Neoplasms; Prospective Studies; Stomach Neoplasms; Taxoids | 2013 |
Disposition kinetics of taxanes after intraperitoneal administration in rats and influence of surfactant vehicles.
Topics: Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Ascites; Docetaxel; Erythrocytes; Excipients; Female; Glycerol; In Vitro Techniques; Injections, Intraperitoneal; Paclitaxel; Permeability; Pharmaceutical Vehicles; Polysorbates; Rats; Surface-Active Agents; Taxoids; Time Factors; Tissue Distribution | 2004 |
Fibrinogen-coated droplets of olive oil for delivery of docetaxel to a fibrin(ogen)-rich ascites form of a murine mammary tumor.
Topics: Animals; Antineoplastic Agents, Phytogenic; Ascites; Docetaxel; Drug Delivery Systems; Female; Fibrinogen; Infusions, Parenteral; Mammary Neoplasms, Animal; Mice; Olive Oil; Plant Oils; Taxoids | 2004 |
[A case of scirrhous carcinoma of the stomach with malignant pleural and peritoneal carcinomatosis responding to the local administration of docetaxel (TXT)].
Topics: Adenocarcinoma, Scirrhous; Adult; Antineoplastic Agents, Phytogenic; Ascites; Docetaxel; Female; Gastrectomy; Humans; Infusions, Intravenous; Infusions, Parenteral; Peritoneal Neoplasms; Peritonitis; Pleural Effusion; Pleural Neoplasms; Quality of Life; Stomach Neoplasms; Taxoids; Thoracic Cavity | 2004 |
[Measurement of docetaxel concentration in blood and ascites after drip infusion into each vessel and intraperitoneal cavity of gastric cancer].
Topics: Antineoplastic Agents, Phytogenic; Ascites; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Gastrectomy; Humans; Infusions, Intravenous; Infusions, Parenteral; Lymph Node Excision; Male; Middle Aged; Stomach Neoplasms; Taxoids | 2004 |
Combination therapy for advanced pancreatic cancer using Herceptin plus chemotherapy.
Topics: Agar; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Ascites; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Deoxycytidine; Docetaxel; Drug Resistance, Neoplasm; Gemcitabine; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Pancreatic Neoplasms; Recombinant Proteins; Taxoids; Time Factors; Trastuzumab | 2005 |
[In vitro chemo-sensitivity MTT assay guided intraperitoneal chemotherapy for malignant ascites].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Ascites; Camptothecin; Cell Survival; Colorectal Neoplasms; Docetaxel; Female; Humans; Injections, Intraperitoneal; Kaplan-Meier Estimate; Male; Middle Aged; Pancreatic Neoplasms; Stomach Neoplasms; Taxoids; Tumor Cells, Cultured | 2006 |
[A case report of advanced gastric cancer with carcinomatous ascites successfully treated by outpatient chemotherapy].
Topics: Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Ascites; Ascitic Fluid; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Male; Middle Aged; Oxonic Acid; Paclitaxel; Peritoneal Neoplasms; Quality of Life; Stomach Neoplasms; Taxoids; Tegafur | 2007 |
[Complete regression after neoadjuvant chemotherapy in locally advanced gastric cancer causing peritonitis carcinomatosa--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Ascites; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Fluorouracil; Gastrectomy; Humans; Male; Middle Aged; Neoadjuvant Therapy; Peritoneal Neoplasms; Peritonitis; Stomach Neoplasms; Taxoids; Treatment Outcome | 2006 |
Comparison of paclitaxel and docetaxel activity on human ovarian carcinoma xenografts.
Topics: Animals; Antineoplastic Agents, Phytogenic; Ascites; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Taxoids; Transplantation, Heterologous | 1994 |
Activity and toxicity of docetaxel (Taxotere) in women with previously treated metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Ascites; Breast Neoplasms; Docetaxel; Edema; Female; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Pleural Effusion; Taxoids; Treatment Failure; Treatment Outcome | 1997 |